Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 29217288

Avelumab in metastatic urothelial carcinoma after platinum failure (JAVELIN Solid Tumor): pooled results from two expansion cohorts of an open-label, phase 1 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2018 Jan
First author
Patel MR

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2018 Jan;19(1):5-7. doi: 10.1016/S1470-2045(17)30901-4.
    note
    Source null
    related pmid
    29217289
    relationship
    Comment in
  2. citation
    Lancet Oncol. 2018 Jul;19(7):e335. doi: 10.1016/S1470-2045(18)30453-4.
    note
    Source null
    related pmid
    30084379
    relationship
    Erratum in
  3. citation
    Transl Cancer Res. 2019 Mar;8(Suppl 2):S130-S132. doi: 10.21037/tcr.2018.12.04.
    note
    Source null
    related pmid
    35117082
    relationship
    Comment in

Authors and identifiers

  1. name
    Patel MR
    type
    Author
  2. name
    Ellerton J
    type
    Author
  3. name
    Infante JR
    type
    Author
  4. name
    Agrawal M
    type
    Author
  5. name
    Gordon M
    type
    Author
  6. name
    Aljumaily R
    type
    Author
  7. name
    Britten CD
    type
    Author
  8. name
    Dirix L
    type
    Author
  9. name
    Lee KW
    type
    Author
  10. name
    Taylor M
    type
    Author
  11. name
    Schöffski P
    type
    Author
  12. name
    Wang D
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Patel MR
    type
    Author
  2. name
    Ellerton J
    type
    Author
  3. name
    Infante JR
    type
    Author
  4. name
    Agrawal M
    type
    Author
  5. name
    Gordon M
    type
    Author
  6. name
    Aljumaily R
    type
    Author
  7. name
    Britten CD
    type
    Author
  8. name
    Dirix L
    type
    Author
  9. name
    Lee KW
    type
    Author
  10. name
    Taylor M
    type
    Author
  11. name
    Schöffski P
    type
    Author
  12. name
    Wang D
    type
    Author
bibliography ids
  1. nci-bib-35c9af109a3805950d5dadcc
book metadata
content sha256
0922ca56364297c31ffca3460c9619c5f3677275ba604e70b93125dfb74fdf12
document type
citation
dois
  1. 10.1016/S1470-2045(17)30900-2
electronic publication date
display
2017 Dec 5
precision
day
year
2017
evidence scope
bibliographic_metadata_only
id
pubmed:29217288
immutable id
pubmed:29217288@0922ca56364297c31ffca3460c9619c5f3677275ba604e70b93125dfb74fdf12
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
1
name
The Lancet. Oncology
nlm unique id
100957246
pages
51-64
volume
19
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2018 Jan;19(1):5-7. doi: 10.1016/S1470-2045(17)30901-4.
    note
    Source null
    related pmid
    29217289
    relationship
    Comment in
  2. citation
    Lancet Oncol. 2018 Jul;19(7):e335. doi: 10.1016/S1470-2045(18)30453-4.
    note
    Source null
    related pmid
    30084379
    relationship
    Erratum in
  3. citation
    Transl Cancer Res. 2019 Mar;8(Suppl 2):S130-S132. doi: 10.21037/tcr.2018.12.04.
    note
    Source null
    related pmid
    35117082
    relationship
    Comment in
outcomes validated
false
pmid
29217288
provenance
batch id
ec9444d0f4cade22eb9f
provider
NCBI PubMed ESummary
record sha256
35bfcf8775b7a4adabf06b6d4b523f4f971bb2c1d1a5a3142346b688e18e26b1
response sha256
6eef0d8cc09b77e73af656f6390cc734befb84fbc4c229b886e81e5d95bece31
retrieved at
2026-09-09T23:47:30.975610+00:00
publication date
display
2018 Jan
precision
month
year
2018
publication types
  1. Clinical Trial, Phase I
  2. Journal Article
  3. Multicenter Study
  4. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/29217288/
title
Avelumab in metastatic urothelial carcinoma after platinum failure (JAVELIN Solid Tumor): pooled results from two expansion cohorts of an open-label, phase 1 trial.

Preserved source evidence · Not medical advice